[METTL3 inhibitor STM2457 improves metabolic dysfunction-associated fatty liver disease by regulating mitochondrial function in mice].

导出 LinkOut

翻译打印收藏纠错

作者： Y,Gao ^[1] ; P,Wang ^[1] ; S,Lu ^[1] ; W,Ma ^[1]

作者单位： Department of Clinical Laboratory Medicine, First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Laboratory Medicine, Jinan 250014, China. ^[1]

关键词 METTL3 STM2457 m6A methylation modification metabolic dysfunction-associated fatty liver disease mitochondria

主题词动物(Animals);小鼠(Mice);疾病模型, 动物(Disease Models, Animal);胰岛素抗药性(Insulin Resistance);脂类代谢(Lipid Metabolism);肝(Liver);小鼠, 近交C57BL(Mice, Inbred C57BL);线粒体(Mitochondria);甲基转移酶类(Methyltransferases)

DOI 10.12122/j.issn.1673-4254.2023.10.06

PMID 37933644

发布时间 2023-11-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

2023年43卷10期

1689-1696页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

[METTL3 inhibitor STM2457 improves metabolic dysfunction-associated fatty liver disease by regulating mitochondrial function in mice].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

相似文献

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

[METTL3 inhibitor STM2457 improves metabolic dysfunction-associated fatty liver disease by regulating mitochondrial function in mice].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

相似文献

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

相关期刊

检索历史清除